.png)
.png)
.png)
.png)
.png)
.png)
About the Study
Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) is a long-term condition that affects millions of people, leading to nasal blockage, breathing difficulties, sinus pain, and a decreased sense of smell. Many current treatment options, including nasal sprays and even surgery, offer only temporary relief—often leading to symptom recurrence.
The CONTRAST-NP clinical study is investigating an investigational medication (lebrikizumab) to determine if it can provide a more effective and lasting treatment option for individuals living with CRSwNP.
If you have been diagnosed with CRSwNP and have received systemic corticosteroids or undergone nasal polyp surgery, this study may be an opportunity to access potential new treatment options and help advance medical research.
.png)
Why This Research Is Important
Chronic Rhinosinusitis with Nasal Polyps is more than just congestion. The condition can significantly impact daily life, leading to:
🔹 Persistent nasal congestion and blockage
🔹 Sinus pain and pressure
🔹 Loss of sense of smell and taste
🔹 Frequent sinus infections
🔹 Difficulty sleeping and breathing properly
For many, current treatment options do not provide long-term relief, and some patients even require repeated sinus surgeries.
The CONTRAST-NP study is researching an investigational treatment that may provide longer-lasting relief by targeting inflammation at its source.
This is an opportunity to be part of medical research that could shape the future of CRSwNP treatment.
Who Can Participate?
You may qualify if you:
Are 18 years or older
Have been diagnosed with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
Have received systemic corticosteroids (oral or injectable) within the last 2 years OR have undergone nasal polyp surgery
Have had ongoing symptoms for at least 8 weeks, including nasal congestion and other sinus-related issues
Are willing to participate in a research study that includes study-related medical visits, symptom tracking, and investigational treatment
Study-related medical care and treatment are provided at no cost. No health insurance is required.
